IL22 and neoplasm: Genetic ablation of IL-22 resulted in a significant decrease in tumor mass and a reduction in the number of tumor cells, their proliferation, and the ability to activate STAT3, and it was also associated with a reduction in angiogenesis and the number of inflammatory cells that infiltrated the lung tissue.